Related Experiment Video
Updated: Mar 2, 2026
09:43
Isolation and Characterization of RNA-Containing Exosomes
Published on: January 9, 2012
100.6K
HFE genotype affects exosome phenotype in cancer
Oliver D Mrowczynski1, A B Madhankumar1, Becky Slagle-Webb1
1Department of Neurosurgery, Pennsylvania State University, College of Medicine, Hershey, PA 17033, United States.
Biochimica Et Biophysica Acta. General Subjects
|May 22, 2017
Summary
Neuroblastoma tumor progression is influenced by exosomes. Genetic changes in the HFE gene alter exosome properties, promoting cancer invasion, angiogenesis, and therapeutic resistance in recipient cells.
Area of Science:
- Oncology
- Cancer Biology
- Exosome Research
Background:
- Neuroblastoma is a common childhood cancer with challenges in diagnosis and treatment monitoring.
- Exosomes play a role in cancer progression, metastasis, and therapy resistance.
- The influence of host genotype on exosome function in cancer is largely unexplored.
Purpose of the Study:
- To investigate the impact of HFE gene genotype on the molecular and functional characteristics of neuroblastoma-derived exosomes.
- To determine if HFE mutations affect exosome cargo related to cancer progression and therapeutic resistance.
Main Methods:
- Analysis of exosomes isolated from human neuroblastoma cells expressing wild-type or mutant HFE.
- Characterization of exosome protein content, focusing on invasion, angiogenesis, and therapeutic resistance markers.
- Functional assays to assess the transfer of exosome cargo to recipient cells and their subsequent oncogenic behavior.
Main Results:
- HFE genotype significantly alters exosome composition and function.
- Exosomes derived from HFE mutant cells exhibit increased expression of proteins associated with invasion and angiogenesis.
- HFE mutant exosomes enhance therapeutic resistance and promote oncogenic functionality in recipient cells.
Conclusions:
- Host genotype, specifically HFE mutations, critically influences exosome phenotype in neuroblastoma.
- HFE mutant exosomes represent a potential mechanism driving tumor progression, metastasis, and treatment failure.
- Targeting HFE-mediated exosome communication may offer novel therapeutic strategies for neuroblastoma.
Related Concept Videos
01:36Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
01:33Pleiotropy
43.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.6K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
56
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
02:32Exon Recombination
4.2K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
4.2K
01:11Genetic Lingo
116.2K
Overview
116.2K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
65
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
65